FBLD 2008 Speakers

Thomas Hesterkamp, Ph.D.

Dr. Thomas Hesterkamp is heading Evotec's Fragment Based Drug Discovery initiative and oversees a number of internal and external projects in that area. Previously he held the position of the Group Leader Biochemical Assays within Evotec's Discovery Biology. In that role he had responsibility from reagent production, assay development to HTS and lead generation biology. Before joining Evotec in 2000 he spent three years with the Swiss pharmaceutical company Arpida as a Research Scientist in the field of drug discovery anti-infectives. Dr Hesterkamp graduated in Human Biology at University of Marburg, Germany where he also obtained his Ph.D. in 1997 with a work on cellular protein folding.